In line with these findings, previous studies have shown that ANG-2/ITGB1–dependent signaling induces EMT and invasion, and thereby contributes to metastasis formation in non-SCLC (NSCLC) (19) and gliomas (18). The gene discussed is ANGPT2; the disease is central nervous system cancer.